Brian A. Leuthner - Jun 28, 2021 Form 4 Insider Report for ONCOSEC MEDICAL Inc (ONCS)

Role: Interim CEO
Signature: /s/ Brian A. Leuthner
Stock symbol: ONCS
Transactions as of: Jun 28, 2021
Transactions value $: -$43,017
Form type: 4
Date filed: 6/29/2021, 07:42 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ONCS	Common Stock	Award	$0	+192K		$0.00	192K	Jun 28, 2021	Direct	F1
transaction	ONCS	Common Stock	Sale	-$43K	-13.6K	-7.09%	$3.16^*	178K	Jun 28, 2021	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ONCS	Stock Option (Right to Buy)	Award	$0	+33K		$0.00	33K	Jun 28, 2021	Common Stock	33K	$3.16	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects restricted stock units (RSUs) that were 25% vested upon grant with the remaining 75% vesting in equal quarterly installments over the next two years.
F2	In connection with the vesting of 48,000 RSUs on June 28, 2021, a total of 13,613 shares were sold in order to satisfy the reporting person's tax withholding obligations. This sale occurred automatically, and the amount sold corresponded to the tax withholding amount. The reporting person had no control with respect to such sale, which was conducted in accordance with the Issuer's corporate policies.
F3	The option is 25% vested upon grant with the remaining 75% vesting in equally in quarterly installments over the next two years.